UK markets closed

TherapeuticsMD, Inc. (TXMD)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
2.2900+0.0100 (+0.44%)
At close: 04:00PM EDT
2.2500 -0.04 (-1.75%)
After hours: 07:52PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.2800
Open2.2600
Bid1.9800 x 100
Ask2.6300 x 100
Day's range2.2555 - 2.3100
52-week range1.9500 - 4.7200
Volume9,722
Avg. volume18,668
Market cap24.217M
Beta (5Y monthly)1.02
PE ratio (TTM)0.47
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    TherapeuticsMD Announces Third Quarter 2023 Financial Results

    BOCA RATON, Fla., November 14, 2023--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the third quarter ended September 30, 2023.

  • Business Wire

    TherapeuticsMD Announces Second Quarter 2023 Financial Results

    BOCA RATON, Fla., August 14, 2023--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the second quarter ended June 30, 2023.

  • Business Wire

    TherapeuticsMD Announces First Quarter 2023 Financial Results

    BOCA RATON, Fla., May 15, 2023--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the first quarter ended March 31, 2023.